MAM
An ode to women’s power
MUMBAI: It’s a befitting ode to all the women out there; a wake-up call for her to realize her true value and potential. This 1.30-minute-long video, produced by Jigsaw Pictures, is based on the creative by Leo Burnett, Mumbai, for Reliance Fresh & Reliance Smart. It tells the story of domestic violence, which unfortunately cuts across all social strata and age group.
The video celebrates the virtues of a woman and exhorts them to understand her true values and shun stigmas associate with unwanted scars and colour. So it’s sign off is: “Women. It’s time. #ChooseYourColour.”
It has already received 7m views and almost 40k shared from Reliance Fresh & Smart. “We received immense response from across the strata of the society. Many likes and shares more from FB, YouTube channel, and thousands from WhatsApp as well,” said Rajnish Lall, Founder & Creative Producer, Jigsaw Pictures.
“The idea stirred me even as a man. The timing, Women’s Day-Holi, is a great opportunity. The concept was great. The trigger was heady for me not to be a part of this. Then all of us became a great team and we made this happen,” he added.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
